SP

Sujaya Padmanabhan Nair

Active Director Managing Director DIN 11303487
DIN 11303487 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sujaya Padmanabhan Nair

Data last updated:

Sujaya Padmanabhan Nair is a Managing Director at Cormedix Pharma Private Limited (since 2025).

DIN 11303487
Primary Designation Managing Director
First Appointment 17 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cormedix Pharma Private Limited U46497GA2025PTC017600
Managing Director17 Sep 20252025Active

Board colleagues of Sujaya Padmanabhan Nair

Directorship timeline

Open interactive timeline →
Cormedix Pharma Private Limited
Premium access

Shareholding and investment profile for Sujaya Padmanabhan Nair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujaya Padmanabhan Nair

Sujaya Padmanabhan Nair currently holds 1 directorship: Cormedix Pharma Private Limited (Managing Director, since 17 Sep 2025).

Sujaya Padmanabhan Nair was first appointed on 17 Sep 2025 as Managing Director at Cormedix Pharma Private Limited.

The current boards of Sujaya Padmanabhan Nair's companies include Bushra (Cormedix Pharma Private Limited), Rifa Muhammed Basheer (Cormedix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available